Bentham Science Logo

Track Your Manuscript:

Current Pharmaceutical Biotechnology

Volume 21, 15 Issues, 2020
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access


Current Pharmaceutical Biotechnology, Volume 12 - Number 2

Cell Reprogramming: A New Chemical Approach to Stem Cell Biology and Tissue Regeneration

, 12(2): 146 - 150

L. Anastasia, M. Piccoli, A. Garatti, E. Conforti, R. Scaringi, S. Bergante, S. Castelvecchio, B. Venerando, L. Menicanti and G. Tettamanti

DOI: 10.2174/138920111794295828

Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment

, 12(2): 196 - 205

A. Nicolini, P. Ferrari, M. Fini, V. Borsari, P. Fallahi, A. Antonelli, P. Berti, A. Carpi and P. Miccoli

DOI: 10.2174/138920111794295657

Parthenogenetic Cell Lines: An Unstable Equilibrium Between Pluripotency and Malignant Transformation

, 12(2): 206 - 212

Tiziana A.L. Brevini, Georgia Pennarossa, Magda de Eguileor, Gianluca Tettamanti, Guido Ragni, Alessio Paffoni and Fulvio Gandolfi

DOI: 10.2174/138920111794295837

Embryonic Morphogenetic Field Induces Phenotypic Reversion in Cancer Cells. Review Article

, 12(2): 243 - 253

M. Bizzarri, A. Cucina, P. M. Biava, S. Proietti, F. D'Anselmi, S. Dinicola, A. Pasqualato and E. Lisi

DOI: 10.2174/138920111794295701

Anabolic Steroid - and Exercise - Induced Cardio-Depressant Cytokines and Myocardial β1 Receptor Expression in CD1 Mice

, 12(2): 275 - 284

Irene Riezzo, Marco Di Paolo, Margherita Neri, Stefania Bello, Santina Cantatore, Stefano D'Errico, Dinuccio Dinucci, Ruggero Parente, Cristoforo Pomara, Roberto Rabozzi, Emanuela Turillazzi and Vittorio Fineschi

DOI: 10.2174/138920111794295792

Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol

, 12(2): 285 - 292

Thomas Pfeifer, Marlene Buchebner, Prakash G. Chandak, Jay Patankar, Adelheid Kratzer, Sascha Obrowsky, Gerald N. Rechberger, Rajendra S. Kadam, Uday B. Kompella, Gerhard M. Kostner, Dagmar Kratky and Sanja Levak-Frank

DOI: 10.2174/138920111794295774


Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens

View Full Editorial Board

COPE Compliant

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.97


How to write and publish your papers in high impact journalsOctober Health DaysPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog